NASDAQ:ALGS

Aligos Therapeutics, Inc.

Company facts

Most recent report
8-K, filed Sep 15, 2026
Incorporated
Delaware
Filings on record
346 filings
On EDGAR
CIK 1799448
Fiscal year ends
December
Filer status
Non-accelerated filer, Smaller reporting company

Financials 8 of 24

News 8 of 56

Prospectuses and Registrations 8 of 21

Proxies 8 of 15

Ownership 8 of 189

Other 8 of 41

Everything here comes from Aligos Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.